Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, ...

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...

Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.

After eleven 11 of survivorship, I’ve been waiting to hear the words, “You’re completely free of cancer! Go in peace,” but ...

Dr. Alexandra Zaleta discussed the impact of administrative delays and insurance red tape experienced by patients with ...

Valarie Traynham sat down for an interview in CURE in which she discussed adjusting to life after cancer, detailing her ‘new normal.’ ...

Ongoing research within the advanced-stage melanoma therapeutic space is beginning to suggest that shorter treatment periods ...

My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and ...

Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after ...

In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.

The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

A cancer thriver reflects on the emotional toll, survivorship, advocacy and support networks they wish they’d known at ...